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Abstract 
Technical azadirachtin, a major component of A. indica leaves, has low acute/subchronic toxicity and non-
mutagenic/teratogenic in mammalian species along with minimal disruption to the ecosystem. The aim of the present study is 
to examine the dose dependent effect of azadirachtin-A on biochemical, sperm functional parameters and fertility performance 
in treated groups. Wistar strain male albino rats were administered subcutaneously with graded concentrations of 
azadirachtin-A (0.5, 1.0 and 1.5 mg in suspension of 50% DMSO, respectively / kg body weight) followed by maintaining 
suitable controls for 24 days. Five animals from each group were used for fertility test. 24 hrs after the last dose, the control 
and treated animals were sacrificed; reproductive organs were then used for biochemical analysis and cauda epididymal 
plasma for sperm analysis. No significant differences in their body weight were observed. However, at high dose level of 1.5 
mg/kg body weight, there was a general decrease in reproductive organs weights, altering in biochemical parameters and 
reduction in the sperm functional parameters with increased abnormal sperms. Furthermore, fertility performance test showed 
30% even at high dose of azadirachtin-A treated for 24 days. In this study such high dose effects may have resulted from the 
deficiency in the level of circulating androgen, probably due to androgen deficiency consequent to the anti-androgenic 
property of azadirachtin-A and using this compound, in effective dose manner, may be a potential candidate as a 
contraceptive agent for the induction of infertility in humans by means of phytochemical approach.  
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Introduction 
Azadirachta indica A.Juss (Syn: Melia Azadirachta 
L, Meliaceae family), commonly known as neem, is an 
important medicinal plant cultivated throughout India 
and Burma. This plant is extensively used as an 
astringent, antiperiodic, antispirochaetal, antiprotozoal; 
leprosy and bronchitis; for healing ulcers in urinary 
passages; for chronic fever and many other disorders 
(Bhakuni et al., 1990). It has been reported that the 
crude oral administration of A.indica leaves exhibit as 
antispermatic, antiandrogenic (Aladakatti & Nazeer 
Ahamed, 2005a, b) and several such effects appear 
reversible (Joshi et al., 1996). Study from Khillare and 
Shrivastav (2003) have been demonstrated and 
confirmed that the lyophilized A.indica leaves extract is 
carbohydrate in nature with spermicidal activity on rat 
spermatozoa. Recently, it has been shown that oral 
administration of lyophilized A.indica leaf powder to 
male rats produced dose-related effects on biochemical 
parameters of testis and epididymis due to changes in 
the chemical composition of testis and the epididymis 
and probably due to a deficiency in the level of 
circulating androgen in the male rats; these results 
indirectly reflect the antiandrogenic property of the 
lyophilized A.indica leaf powder (Aladakatti et al., 2010). 
Neem product has been widely used in agriculture 
as an alternative to synthetic pesticides (Anon, 1992). 
A number of chemical components have been isolated 
from neem plant extract. Many of the secondary 
compounds of the neem have been identified (Van der 
Nat et al., 1991), purified and some have been tested 
for their effects on mammals. These include for 
example azadirachtin, nimbolide and nimbinin, solannin, 
deacetylazadirchtinol, nimbin, nimbidinin and 
meliantriol all being biologically active compounds of 
neem. Azadirachtin (Fig) is a triterpenoid of the class of 
limonoids, found in three species, the trees Azadirachta 
indica (Schmutterer, 2002, Rutales: Meliaceae), A. 
excelsa (Schmutterer et al., 2002), and A. siamensis 
(Sombatsiri et al., 2002).  
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Fig. Chemical structure of azadirachtin 
 
 
 
 
 
 
 
 
 
 
 
It is chemically interesting because of its complex 
structure and the challenge its synthesis provided; and 
moreover, the chemistry, environmental behaviour and 
biological effects of azadirachtin have been reviewed 
(Sundaram, 1996). Although, technical azadirachtin, 
molecular weight of 720.2, has low acute/subchronic 
toxicity and non-mutagenic/teratogenic in mammalian 
species, with LD50 greater than 5000 mg/kg in the rat 
(Raizada et al., 2001), consequently the possibility of 
future hazards of neem products therefore should not 
be ignored (Anon, 1992). A recent wide scale use of 
azadirachtin in agriculture, the population in general 
and vulnerable groups such as virgin or pregnant 
women in particular may be exposed continuously 
throughout several generations.  In order to establish 
their potential use, though various experimental studies 
reported by using this plant sources on biochemical 
and sperm parametric studies are available, it is very 
much required to evaluate the 
antiandrogenic/antifertility nature of the azadirachtin-A 
from the neem leaves. Based on the current available 
data, the present experimental study has therefore 
been designed to study the effect of azadirachtin –A on 
the androgen dependent reproductive organs at a dose 
dependent manner.  The present work mainly deals 
with the determination of some of the androgen 
dependent biochemical parameters like estimation of 
protein, free sugar content, acid phosphatase (ACP), 
alkaline phosphatase (ALP) and lactate dehydrogenase 
(LDH) in the reproductive organs, sperm functional 
parameters and fertility in both the control and treated 
rats. 
 
Materials and Methods 
Animals: Colony bred healthy adult male albino rats 
(Wistar strain) weighing 200 g were utilized for 
experiments. All animals were proven fertility and 
obtained from the rat colony maintained in the 
department. They were housed at a temperature of 22 
± 20 C and exposed to 12-12 h of daylight and 
maintained on a standard rat pellet diet and water was 
given ad libitum. The animals were acclimatized to the 
laboratory conditions before conducting experiments 
and the care of the laboratory animals was taken as 
per the Committee for the Purpose of Control and 
Supervision of Experiments on Animals (CPCSEA) 
regulations.   
 
Chemicals: Reagents were obtained as follows:  
Technical Azadirachtin-A (from SPIC Ltd., Chennai, 
India). All other reagents were from either Sigma or Hi 
Media Lab Pvt. Ltd. (Mumbai, India).  
 
Treatment: In this study, the concentration of 
azadirachtin-A was used in vivo, i.e., 0.5, 1.0 and 1.5 
mg / kg body weight were calculated as described from 
the studies of Glinsukon et al. (1986). The different 
concentrations of azadirachtin-A dissolved in 50% 
Dimethyl sulfoxide (DMSO) and administered to rats by 
subcutaneous injection using a micro-syringe. Forty 
male rats were divided into four groups of 10 animals 
each. The rats in group A were administered with 50% 
DMSO (vehicle control; 5 mL / kg body weight), while 
the rest treatment three groups (B, C, and D) were 
administered with graded doses of azadirachtin-A of 
0.5, 1.0 and 1.5 mg/kg body weight, respectively. The 
DMSO and the graded doses of azadirachtin-A were 
administered subcutaneously on daily for 24 days. Five 
animals from each group were used for fertility test. 
Twenty-four hours after the last dose, the control and 
treated animals were sacrificed by cervical dislocation. 
The testis, epididymis of caput and cauda, vas 
deferens, seminal vesicle and ventral prostate were 
dissected out, blotted free of mucus and weighed to the 
nearest milligram used for biochemical and sperm 
functional parameters.  
 
Biochemical analysis 
50-100 mg of each tissue was quantitatively 
homogenized in 1 ml of 0.1 M Tris-Hcl buffer (pH 7.2), 
0.1 M phosphate buffer (pH 7.2) or distilled water and 
then centrifuged at 8000 g for 15 minutes at 4°C. The 
supernatants were collected and used for various 
biochemical analysis using Hitachi.U.V. Vis. 
Spectrophotometer. 
 
i) Estimation of total protein: The total protein level in 
the testis was estimated by the method of Lowry et al 
(1951) using Bovine Serum Albumin as standard. The OD 
of the resultant colour was read at 660nm and expressed 
as mg protein per gm wet tissue. 
 
ii) Estimation of total free sugar: The total free sugar 
content of the tissue was estimated following the method 
of Folin and Wu (Oser, 1965). The O.D. was recorded at 
420 nm and expressed as mg sugar per gm wet tissue. 
 
iii) Estimation of acid phosphatase (ACP) and alkaline 
phosphatase (ALP): The enzyme assays were carried 
out according to the method described by Andersch and 
Szezypinski (1947). The O.D. of the resultant colour was 
read on a colorimeter at 400nm and both phosphatase 
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activities were expressed in terms of m Moles of P-
nitrophenol formed per hour per gram protein. 
 
iv) Estimation of lactate dehydrogenase (LDH): LDH 
levels in the testis were determined by the method of King 
(1965) .The intensity of the colour was measured at 440 
nm and expressed as μ Mole/gm/hr. 
 
Sperm analysis  
For the standard sperm analysis, the cauda 
epididymis from each animal was chopped into 
phosphate buffered glucose saline (PBGS: 
Composition: Nacl / 50 mM / l, Na2 HPO4 200 m M / l, 
glucose 200 mM/l, KH2PO4 26 mM/l).  The debris was 
removed and the epididymal suspension was used for 
sperm analysis.  The following observations were made: 
(i)Total number of sperms per ml; ( ii) Total number of 
motile sperms per ml; (iii)Normal and abnormal sperm 
count (relative percentage); and (iv)Forward velocity of 
the sperm i.e., μm/sec. 
The total sperm count was calculated by the 
method of Besley et al., (1980), using Neubauer 
haemocytometer.  To increase the accuracy of sperm 
count, the epididymal plasma was diluted with a 
spermicidal solution, prepared by dissolving 5 g of 
NaHCO3 and 1 ml of 40 % formaldehyde in 100 ml of 
normal saline.  A twenty times dilution was made by 
using W.B.C pipette, which was thoroughly mixed and 
one drop was added to both sides of Neubauer 
haemocytometer. The sperms were allowed to settle 
down in the haemocytometer by keeping them in a 
humid chamber for one hour.  The sperm count was 
done in R.B.C counting 5 major squares designated E1, 
E2, E3, E4 and a central E5.  Each square is 1 mm long, 
1 mm wide and 0.1 mm of height.  The total volume 
represented by each major square E is thus 0.1 mm3 or 
10-4 mm.  The total number of sperms were counted in 
all the major squares and calculated as follows.              
 
 
 
Similarly the total number of motile sperms was 
calculated, using PBGS instead of spermicidal solution.  
 
The relative proportion of the normal and 
abnormal sperms were calculated by smear 
preparation according to the method of Bauer et al., 
(1974). Equal volume of cauda epididymal plasma and 
5 % sodium bicarbonate were taken in a centrifuge 
tube, mixed well and centrifuged for 5 minutes at 4000 
g.  The supernatant was discarded and to the 
precipitate 5 ml of normal saline was added, mixed well 
and centrifuged again.  The procedure was repeated 2 
to 3 times and a clear precipitate was obtained.  To the 
final precipitate few drops of normal saline were added, 
mixed thoroughly and a smear was prepared on a 
clean slide.  The smear was dried at room temperature, 
fixed by heating it over the flame for two to three 
seconds.  Then the smear was flushed with 95 % 
alcohol, drained and dried.  It was stained in Ziehl 
Neelson's Carbol Fuchsin diluted with equal volume of 
95% alcohol for 3 minutes and counter stained with 1:3 
(v/v) aqueous solution of Loeffer's methylene blue for 2 
minutes.  After staining, the smear was rinsed in water 
and dried in air. The abnormal sperms included 
categories like double tailed, detached head, detached 
tail, mid piece bending and irregular head.  The relative 
proportion of the normal and abnormal sperms was 
from the smear and expressed in terms of percentage. 
To assess the forward velocity of sperms, the 
method of Ratnasoorya (1984) was adopted. The 
epididymal plasma was suspended in PBGS, cleared 
the tissue debris and a clear solution was used for the 
assessment of average forward velocity of sperms.  
The assessment was made under light microscope, 
fitted with a movable mechanical stage and a calibrated 
ocular micrometer, at 400 X magnification.  A drop of 
sperm suspension was transferred to a clean glass 
slide and the initial place and time of each sperm was 
recorded.  The time taken for forward movement of 
sperm from the initial place within microscopic field was 
recorded using a stop watch.  The procedure was 
repeated for 10 spermatozoa in each sample and the 
average forward velocity of sperm was calculated and 
expressed as μm / sec. 
 
Fertility test  
To assess the fertility rate with reference to the 
number of implantations, the remaining five males per 
group were paired with female of proven fertility 
exhibiting regular estrous cycles and were separately 
housed with the B,C, D of azadirachtin-A treated rats 
and left overnight. The appearance of sperm in the 
vaginal smear next morning confirmed the mating and 
is considered as day 1 of the pregnancy. After 8 days, 
the females were laparotomized and the number of 
implantations were recorded.  
 
Statistical analysis 
Results are expressed as the mean value ± 
standard error of mean (S.E.M.). All percentage data 
were subjected either to Student’s t-test or one-way 
analysis of variance (ANOVA) followed by multiple t-
tests for analysis. 
 
Results  
Body and organ weights in azadirachtin-A treated 
rats: The body weight of the rats did not differ due to 
the dose dependent treatment of azadirachtin-A.  In 0.5 
mg / kg body weight rats (group B), the weights of 
testis and other accessory structures remain 
unchanged excluding seminal vesicle and ventral 
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prostate (P ≤ 0.05) when compare to controls. 
Whereas, groups C and D (1.0 mg and 1.5 mg / kg 
body weight), exhibited a significant decrease in the 
weight of ventral prostate (P ≤ 0.01 and P ≤ 0.001 
respectively). Testis and seminal vesicle of 1.5 mg / kg 
treated shown significant decrease (P ≤ 0.01) in their 
weights. However, there were decrease (P ≤ 0.05) in 
the weights of epididymis (both caput and cauda) and 
vas deference in 1.0 mg and 1.5 mg treated groups 
when compare to controls (group A, Table.1).
 
 
Table 1: Dose dependent effect of azadirachtin-A on the body weight (g) and reproductive organs weights (mg) of albino rats 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data are mean ± S.E.M. of 5 replicates 
* Significant difference at p < 0.05 level, when compared with control group 
**Significant difference at p < 0.01 level, when compared with control group 
***Significant difference at p < 0.001 level, when compared with control group 
 
Androgen dependent biochemical parameters in 
azadirachtin-A treated rats: Biochemical composition 
of protein, free sugar content, ACP, ALP and LDH in 
the testis, epididymis (caput and cauda), vas deferens, 
seminal vesicle and ventral prostate were observed in 
the control and dose dependent concentration of 
azadirachtin-A treated rats.  
 
Protein content in testis and other reproductive 
organs: The protein content in testis was reduced in 
1.5 mg (group D) of azadirachtin-A / kg body weight 
treated rats (P ≤ 0.05) and in 0.5 mg (Group B) and 1.0 
mg (Group C) treated rats, there was no difference in 
the protein content when compare to controls (group A, 
37.30 ± 1.08 mg/g, Table.2). In epididymis of group D, 
the protein content of cauda was significantly reduced 
(P ≤ 0.01) and caput (group D) and cauda (group C) 
exhibited reduction in protein content (P ≤ 0.05). 
However, in group B and caput of group C, there was 
no difference in the protein content when compare to 
controls of both caput and cauda (46.93 ± 1.34 mg/g 
and 36.42 ± 2.19 mg/g respectively, Table.3). In vas 
deference, the protein content was significantly 
reduced (P ≤ 0.01) in group D, reduction in group C (P 
≤ 0.05) and no difference in group B when compare to 
controls (group A, 46.53 ± 2.16 mg/g, Table.4). In 
seminal vesicle, the protein content was significantly 
reduced (P ≤ 0.01) in groups C and D and no 
difference in group B when compare to controls (group 
A, 50.49 ± 1.04 mg/g, Table.5). In ventral prostate, the 
protein content was highly significant (P ≤ 0.01) in 
group D and significantly reduced (P ≤ 0.01) in group C 
and no difference in group B when compare to controls 
(group A, 70.65 ± 1.05 mg/g, Table. 6). 
  
 
 
 
 
Group Body 
weight 
Testis Epididymis Vas 
deferens 
Seminal 
vesicle 
Ventral 
prostate  Caput Cauda 
Group A 
Phosphate 
buffer saline 
(PBS, 
5 mL kg -1 BW) 
 
205.00 ± 
3.76 
 
 
695.05 ± 
2.57 
 
 
137.28 ± 
2.87 
 
 
116.51 ± 
2.04 
 
168.88 ± 
3.26 
 
 
601.33 ± 
7.26 
 
 
381.92 ± 
12.58 
 
Group B 
Azadirachtin- A  
(0.5 mg / kg -1 
BW) 
 
211.85 ± 
2.48 
 
 
684.18 ± 
3.73 
 
 
138.86 ± 
1.31 
 
 
115.39 ± 
3.93 
 
 
173.72 ± 
2.14 
 
629.71 ± 
5.23 
 
372.71 ± 
5.23 
Group C 
Azadirachtin- A  
(1.0 mg / kg -1 
BW) 
 
 
205.57 ± 
3.22 
 
 
670.27 ± 
2.03* 
 
 
136.53 ± 
2.20 
 
 
112.55 ± 
3.76* 
 
 
161.43 ± 
3.12* 
 
589.65 ± 
4.92* 
 
366.35 ± 
11.92** 
Group D 
Azadirachtin- A  
(1.5 mg / kg -1 
BW) 
 
 
195.83 ± 
2.45 
 
 
657.10 ± 
4.12** 
 
 
132.60 ± 
2.33* 
 
 
108.35 ±  
2.49* 
 
 
152.23 ± 
4.02* 
 
 
551.21 
±12.34** 
 
 
335.21 
±10.27*** 
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Table 2: Dose dependent effect of azadirachtin-A on various biochemical analysis of the Testis of albino rats 
Data are mean ± S.E.M. of 5 replicates 
* Significant difference at p < 0.05 level, when compared with control group 
**Significant difference at p < 0.01 level, when compared with control group 
***Significant difference at p < 0.001 level, when compared with control group 
 
Table 3: Dose dependent effect of azadirachtin-A on various biochemical analysis of the caput and cauda of epididymis of albino rats 
 
Group Protein (mg/g) Sugar(mg/g) 
Acp(mM/g/hr) Alp (mM/g/hr) LDH (µM/g/hr) 
Caput Cauda Caput Cauda Caput Cauda Caput Cauda Caput Cauda 
Group A 
Phosphate buffer 
saline (PBS, 
5 mL kg -1 BW) 
46.93± 
1.34 
 
36.42± 
2.19 
 
0.62 ± 
0.03 
 
0.72± 
0.02 
 
10.91± 
0.06 
 
8.01± 
0.06 
 
1.01± 
0.05 
 
1.25± 
0.04 
 
302.3± 
4.87 
 
374.4± 
4.91 
 
Group B 
Azadirachtin- A  
(0.5 mg / kg -1 
BW) 
46.65± 
1.40 
 
33.74± 
1.17 
 
0.93± 
0.02 
 
1.71± 
0.03* 
 
9.86± 
0.03 
 
7.17± 
0.05 
 
1.58± 
0.03 
 
2.40± 
0.02* 
 
318.7± 
4.80 
 
544.3± 
4.54** 
 
Group C 
Azadirachtin- A  
(1.0 mg / kg -1 
BW) 
 
45.01± 
1.11 
 
29.65± 
1.20* 
 
1.15± 
0.03* 
 
2.63± 
0.02** 
 
8.58 ± 
0.03* 
 
6.10± 
0.03* 
 
2.20± 
0.05* 
 
2.98± 
0.02* 
 
422.0± 
5.06** 
 
679.7± 
4.78*** 
 
Group D 
Azadirachtin- A  
(1.5 mg / kg -1 
BW) 
 
40.66± 
1.57* 
 
23.71± 
1.19** 
 
1.98± 
0.03* 
 
4.11± 
0.03*** 
 
6.50 ± 
0.05** 
 
4.28± 
0.05** 
 
3.80± 
0.02** 
 
3.64± 
0.03** 
 
567.7± 
4.77*** 
 
773.8± 
4.65*** 
 
Data are mean ± S.E.M. of 5 replicates 
* Significant difference at p < 0.05 level, when compared with control group 
**Significant difference at p < 0.01 level, when compared with control group 
***Significant difference at p < 0.001 level, when compared with control group 
 
 
 
 
 
 
 
 
 
 
 
Group 
 
 
Protein 
 (mg/g) 
 
Sugar 
(mg/g) 
 
Acp 
 (mM/g/hr) 
 
Alp  
(mM/g/hr) 
 
LDH 
 (µM/g/hr) 
Group A 
Phosphate buffer saline 
(PBS, 
5 mL kg -1 BW) 
 
37.30 ± 1.08 
 
 
0.60 ±  0.03 
 
 
2.96 ±  0.06 
 
 
1.22 ± 0.04 
 
 
268.28 ± 4.92 
Group B 
Azadirachtin- A  
(0.5 mg / kg -1 BW) 
 
36.36 ± 1.10 
 
 
0.76 ± 0.02 
 
 
2.80 ± 0.03 
 
 
1.78 ± 0.11 
 
 
286.35 ±  4.91* 
 
Group C 
Azadirachtin- A  
(1.0 mg / kg -1 BW) 
 
 
34.91 ± 0.88 
 
 
1.38 ±  0.03 
 
 
2.08 ± 0.03 
 
 
3.60 ± 0.04* 
 
 
373.89 ± 4.74** 
 
Group D 
Azadirachtin- A  
(1.5 mg / kg -1 BW) 
 
 
30.90 ± 0.96* 
 
 
2.30 ±  0.02* 
 
 
1.51 ±  0.05* 
 
 
4.22 ±  0.03** 
 
 
519.93  ± 4.85*** 
 
Ravindranath et al./Rec Res Sci Tech 3 (2011) 34-46 
 
Table 4: Dose dependent effect of azadirachtin-A on various biochemical analysis of the Vas deferens of albino rats 
 
 
Group 
 
 
Protein  
(mg/g) 
 
Sugar 
(mg/g) 
 
Acp 
 (mM/g/hr) 
 
Alp  
(mM/g/hr) 
 
LDH  
(µM/g/hr) 
Group A 
Phosphate 
buffer saline 
(PBS, 
5 mL kg -1 
BW) 
 
46.53 ±  
2.16 
 
 
1.86 ±  
0.02 
 
 
4.89± 
 
 
1.03 ± 
 
 
363.7± 
 
Group B 
Azadirachtin- 
A  
(0.5 mg / kg -
1 BW) 
 
45.49 ±  
2.22 
 
 
2.80 ± 
 
 
4.58± 
 
 
0.96 ± 
 
 
510.5± 
 
Group C 
Azadirachtin- 
A  
(1.0 mg / kg -
1 BW) 
 
 
42.41 ±  
2.24* 
 
 
3.17 ± 
 
 
4.18± 
 
 
1.08 ± 
 
 
671.9± 
 
Group D 
Azadirachtin- 
A  
(1.5 mg / kg -
1 BW) 
 
 
40.64 ±  
2.14** 
 
 
3.76± 
 
 
3.94± 
 
1.12 ± 
 
 
729.8± 
 
Data are mean ± S.E.M. of 5 replicates 
* Significant difference at p < 0.05 level, when compared with control group 
**Significant difference at p < 0.01 level, when compared with control group 
***Significant difference at p < 0.001 level, when compared with control group 
 
Table 5: Dose dependent effect of azadirachtin-A on various biochemical analysis of the Seminal vesicle of albino rats 
 
 
Group 
 
 
Protein  
(mg/g) 
 
Sugar 
(mg/g) 
 
Acp 
 (mM/g/hr) 
 
Alp  
(mM/g/hr) 
 
LDH  
(µM/g/hr) 
Group A 
Phosphate buffer 
saline (PBS, 
5 mL kg -1 BW) 
 
50.49 ± 1.04 
 
 
0.66 ± 
 
 
4.43 ± 
 
 
1.18 ± 
 
 
356.6± 
 
Group B 
Azadirachtin- A  
(0.5 mg / kg -1 BW) 
 
49.51 
 
 
2.40 ± 
 
 
 
4.10 ± 0.06 
 
 
1.40 ± 
 
 
618.4± 
 
Group C 
Azadirachtin- A  
(1.0 mg / kg -1 BW) 
 
 
45.48 
 
 
3.67 ± 
 
 
3.86 ± 
 
 
2.27 ± 
 
 
759.8± 
 
Group D 
Azadirachtin- A  
(1.5 mg / kg -1 BW) 
 
 
41.75 
 
 
4.17 ± 0.02** 
 
 
3.38 ± 
 
 
3.62 ± 
 
 
823.7±  4.75*** 
 
   Data are mean ± S.E.M. of 5 replicates 
* Significant difference at p < 0.05 level, when compared with control group 
**Significant difference at p < 0.01 level, when compared with control group 
***Significant difference at p < 0.001 level, when compared with control group 
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Table 6: Dose dependent effect of azadirachtin-A on various biochemical analysis of the Ventral prostate of albino rats 
 
 
Group 
 
 
Protein  
(mg/g) 
 
Sugar 
(mg/g) 
 
Acp 
 (mM/g/hr) 
 
Alp  
(mM/g/hr) 
 
LDH  
(µM/g/hr) 
Group A 
Phosphate buffer 
saline (PBS, 
5 mL kg -1 BW) 
 
70.65 ± 1.05 
 
 
0.76 ± 
 
 
5.54 ± 
 
 
1.05 ± 
 
 
372.3 ± 4.89 
 
Group B 
Azadirachtin- A  
(0.5 mg / kg -1 
BW) 
 
68.99 ± 0.87 
 
 
2.16 ± 
 
 
 
4.66 ± 
 
 
1.18 ± 
 
 
644.3 ± 4.86** 
 
Group C 
Azadirachtin- A  
(1.0 mg / kg -1 
BW) 
 
 
62.99 ± 0.80** 
 
 
3.85 ± 
 
 
4.32  ± 
 
 
1.84 ± 
 
 
719.8 ± 4.72*** 
 
Group D 
Azadirachtin- A  
(1.5 mg / kg -1 
BW) 
 
 
55.76 ±  0.91*** 
 
 
5.57 ± 
 
 
3.18 ± 
 
   
2.30 ±  0.03* 
 
  817.8 ±  4.84*** 
Data are mean ± S.E.M. of 5 replicates 
* Significant difference at p < 0.05 level, when compared with control group 
**Significant difference at p < 0.01 level, when compared with control group 
***Significant difference at p < 0.001 level, when compared with control group 
 
Sugar content in testis and other reproductive 
organs: The free sugar content in testis was increased 
1.5 mg (group D) of azadirachtin-A / kg body weight 
treated rats (P ≤ 0.05) and in 0.5 mg (Group B) and 1.0 
mg (Group C) treated rats, there was no difference in 
the sugar content when compare to controls (group A, 
0.60 ± 0.03 mg/g, Table.2). In epididymis of groups D 
and C, the sugar content of cauda was increased with 
highly significant and significant (P ≤ 0.001, P ≤ 0.01 
respectively) and increased (P ≤ 0.05) in group B. 
However, sugar content of caput increased in groups C 
and D (P ≤ 0.05) and no difference in group B when 
compare to controls of both caput and cauda (0.62 ± 
0.03 mg/g and 0.72 ± 0.02 mg/gm respectively, 
Table.3). In vas deference, the sugar content was 
increased in groups D and C (P ≤ 0.05) and no 
difference in group B when compare to controls (group 
A, 1.86 ± 0.02 mg/g, Table.4). In seminal vesicle, the 
sugar content was significantly increased (P ≤ 0.01) in 
groups C and D and increased in group B when 
compare to controls (group A, 0.66 ± 0.03 mg/g, 
Table.5). In ventral prostate, the sugar content was 
increased highly significant (P ≤ 0.001) in group D and 
significantly in (P ≤ 0.01) in group C. whereas it 
increased in group B (P ≤ 0.05) when compare to 
controls (group A, 0.76 ± 0.02 mg/g, Table.6). 
 
Acid phosphatase concentration (ACP) in testis 
and other reproductive organs: In testis, the ACP 
activity was reduced in 1.5 mg (group D) of 
azadirachtin-A / kg body weight treated rats (P ≤ 0.05) 
and in 0.5 mg (Group B) and 1.0 mg (Group C) treated 
rats, there was no difference in the activity when 
compare to controls (group A, 2.96 ± 0.06 mM/g/hr, 
Table.2). In epididymis of group D, the activity of caput 
and cauda was significantly reduced (P ≤ 0.01) and 
reduction in the activity of both caput and cauda of 
group C (P ≤ 0.05). However, in group B, there was no 
difference in the activity when compare to controls of 
both caput and cauda (10.91 ± 0.06 mM/g/hr and 8.01 
± 0.06 mM/g/hr respectively, Table.3). In vas deference, 
the activity was reduced in groups C and D (P ≤ 0.05) 
and no difference in group B when compare to controls 
(group A, 4.89 ± 0.05 mM/g/hr, Table.4). In seminal 
vesicle, the activity was reduced significantly in group 
D (P ≤ 0.01) and reduction in the group C (P ≤ 0.05). 
However, there was no difference in group B when 
compare to controls (group A, 4.43 ± 0.06 mM/g/hr, 
Table.5). In ventral prostate, the activity was significant 
in group D (P ≤ 0.01) and no difference in groups B 
and C when compare to controls (group A, 5.54 ± 0.03 
mM/g/hr, Table.6).     
 
Alkaline phosphatase concentration (ALP) in testis 
and other reproductive organs: In testis, the ALP 
activity was significantly increased in 1.5 mg (group D) 
of azadirachtin-A / kg body weight treated rats (P ≤ 
0.01). However, there was a gradual increase in 1.0 mg 
(Group C, P ≤ 0.05) and no difference in the activity of 
group B when compare to controls (group A, 1.22 ± 
0.04 mM/g/hr, Table.2). In epididymis of group D, the 
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activity of caput and cauda was significantly increased 
(P ≤ 0.01) and exhibited increased activity in group C 
and cauda of group B (P ≤ 0.05). However, caput of 
group B, there was no difference in the activity when 
compare to controls of both caput and cauda (1.01 ± 
0.05 mM/g/hr and 1.25 ± 0.04 mM/g/hr respectively, 
Table.3). In vas deference, this activity exhibited 
absolutely no difference in all groups when compare to 
controls (group A, 1.03 ± 0.05 mM/g/hr, Table.4). In 
seminal vesicle, the activity was significantly increased 
(P ≤ 0.01) in group D and a gradual increase group C 
(P ≤ 0.05). Whereas no difference in group B when 
compare to controls (group A, 1.18 ± 0.05 mM/g/hr, 
Table.5). In ventral prostate, the activity was increased 
in groups C and D (P ≤ 0.05) and no difference in 
group B when compare to controls (group A, 1.05 ± 
0.04 mM/g/hr, Table.6).  
 
Lactate dehydrogenase concentration (LDH) in 
testis and other reproductive organs: The LDH 
activity in testis was increased highly significant in 1.5 
mg (group D) of azadirachtin-A / kg body weight treated 
rats (P ≤ 0.001). Whereas significantly increased in 1.0 
mg (Group C) and gradual increased in 0.5 mg (Group 
B) when compare to controls (group A, 268.28 ± 4.92 
µM /g/hr, Table.2). In epididymis of group D, the 
activity of both caput and cauda was increased highly 
significant (P ≤ 0.001) and cauda of group C exhibited 
highly significant (P ≤ 0.001). However, in caput of 
group C and cauda of group B revealed increase their 
LDH activity with significant (P ≤ 0.05). However, caput 
of group B, there was no difference in the activity when 
compare to controls of both caput and cauda (302.3 ± 
4.87 µM /g/hr and 374.4 ± 4.91 µM /g/hr respectively, 
Table.3). In vas deference, the activity was increased 
highly significant  in groups C and D (P ≤ 0.001) and 
increased with significantly in group B (P ≤ 0.01) when 
compare to controls (group A, 363.7 ± 4.82 µM /g/hr, 
Table.4). In seminal vesicle, the activity was increased 
highly significant in groups C and D  (P ≤ 0.001)and 
increased with significantly in group B (P ≤ 0.01) when 
compare to controls (group A, 356.6 ± 4.80 µM /g/hr, 
Table.5). In ventral prostate, the activity was increased 
highly significant  in groups C and D (P ≤ 0.001) and 
increased with significantly in group B (P ≤ 0.01) when 
compare to controls (group A, 373.3 ± 4.89 µM /g/hr, 
Table.6).  
 
Sperm parameters and fertility in azadirachtin-A 
treated rats: Analysis of sperm parameters, such as total 
sperm count, total number of motile sperms, forward 
velocity of the sperm and percentage of abnormal sperm 
of the cauda of epididymal plasma were carried out in the 
control and all azadirachtin-A treated animals. The control 
rats (Group A) showed 56.20 X 104 total number of 
sperms / ml epididymal fluid,   51.80 X 104 number of 
motile sperms / ml epididymal fluid with a speed of 127.2 
μm / sec and 11.20 % of abnormal sperms were recorded 
(Table.7) Where as in the treated animals (Groups B, C & 
D), the abnormal sperms in cauda epididymal plasma of 
albino rats are doses dependent. With a dose of 0.5 mg of 
azadirachtin-A / kg body weight treated rats (Group.B), 
the animals showed no difference in the total sperm count 
(53.60 X 104 / ml), total number of motile sperms (50.60 X 
104 / ml), forward velocity of the sperm (128.2 μm / sec) 
and the percentage of abnormal sperms (11.40%). In 1.0 
mg treated rats (Group.C), the animals showed a 
significant decrease (P ≤ 0.01) in forward velocity of 
sperm (105.4 μm / sec) and the percentage of abnormal 
sperms (23.20%). Whereas, there were decrease (P ≤ 
0.05) in the total sperm count (49.20 X 104 / ml) and total 
number of motile sperm (44.20 X 104 / ml). However, in 
maximum dose of 1.5 mg of azadirachtin-A / kg body 
weight treated rats (Group.D), the animals showed highly 
significant decrease (P ≤ 0.001) in the in forward velocity 
of sperm (90.60 μm / sec) and the percentage of 
abnormal sperms(41.60%). In addition, there were 
significant (P ≤ 0.01) decrease in the total sperm count 
(37.60 X 104 / ml) and total number of motile sperm (30.60 
X 104 / ml) when compare to control animals (Group A).  
 
Discussion   
Besides its therapeutic efficacies, neem has 
already established its potential as a source of naturally 
occurring insecticide, pesticide and agrochemicals. 
Furthermore, evaluation of safety aspects of different 
parts of neem and neem compounds along with 
commercial formulations are also taken into 
consideration. Though, systematic scientific knowledge 
on neem are reported so far, it is also necessary and 
essential for adequate safety evaluation of those 
derived preparations in order to develop a potential 
drug without side effects by means of phytotherapy 
research. Reports from the earlier subchronic toxicity 
study of azadirachtin in rats for 90 days did not show 
any adverse effects, as evidenced by organ to body 
weight ratio, clinical enzyme assay, histopathological 
and hematological parameters (Raizada et al., 2001); 
further, at the tested doses, it did not induce fetal death 
or any malformations (Srivastava and Raizada , 2007). 
This experiment was designed to study primarily the 
technical azadirachtin (purity 95%) on androgen 
dependent biochemical, sperm functional status and 
antifertility performance in rats following its 
subcutaneous injection after dissolved in 50% DMSO 
at three concentrations.  
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Table 7: Dose dependent effect of azadirachtin-A on various sperm parameters of cauda epididymal plasma in albino rats 
 
 
 
Group 
 
 
 
Sperm 
count 
(Total 
No. x 
104/ml) 
 
Motile 
sperm 
(Total 
No. x 
104/ml) 
 
Forward velocity 
(µm/sec) 
 
Abnormal 
sperms 
(%) 
Group A 
Phosphate 
buffer saline 
(PBS, 
5 mL kg -1 
BW) 
 
56.20 ±  
3.07 
 
51.80 ± 
2.91 
 
 
127.2± 3.07 
 
 
11.20 ± 
3.07 
 
Group B 
Azadirachtin- 
A  
(0.5 mg / kg -1 
BW) 
 
53.60 ±  
4.80 
 
50.60 ± 
4.80 
 
 
128.2 ± 4.80 
 
 
11.40 ± 
4.16 
Group C 
Azadirachtin- 
A  
(1.0 mg / kg -1 
BW) 
 
 
49.20 ± 
4.90* 
 
44.20 ±  
4.90* 
 
105.4 ± 4.90** 
 
 
23.20 ± 
4.90** 
 
Group D 
Azadirachtin- 
A  
(1.5 mg / kg -1 
BW) 
 
 
37.60 ±  
4.80** 
 
30.60 ±  
4.80** 
 
 
90.6 ± 3.07*** 
 
41.60 ± 
4.80*** 
 
Data are mean ± S.E.M. of 5 replicates 
* Significant difference at p < 0.05 level, when compared with control group 
**Significant difference at p < 0.01 level, when compared with control group 
         ***Significant difference at p < 0.001 level, when compared with control group 
 
 
Table 8: Dose dependent effect of azadirachtin-A on the implantations of female rats 
 mated with treated male rats 
 
Group 
 No. of Implantations  
Group A 
Phosphate buffer saline (PBS, 
5 mL kg -1 BW) 
 
10.66 ± 0.95 
Group B 
Azadirachtin- A  
(0.5 mg / kg -1 BW) 
 
9.50 ± 0.67 
Group C 
Azadirachtin- A  
(1.0 mg / kg -1 BW) 
 
8.75 ± 0.56 
Group D 
Azadirachtin- A  
(1.5 mg / kg -1 BW) 
 
7.35 ± 0.47* 
Data are mean ± S.E.M. of 5 replicates. 
* Significant difference at p < 0.05 level, when compared with control group 
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Administration of high dose of azadirachtin (1.5 
mg/kg body weight) for 24 days has shown that the 
body weight of rats did not altered other than a 
decrease in the mean testis, seminal vesicle and 
ventral prostate organs weights. However, low doses of 
azadirachtin (0.5 and 1.0 mg/kg body weight have not 
produced any such changes in rats. It is known that 
monitoring body weight provides information on the 
general health of animals, which is important to the 
interpretation of reproductive effects (US EPA, 1996). 
The present data show that the reduction in the testis, 
seminal vesicle and ventral prostate organs weights at 
high dose may be due to the decrease in serum 
testosterone concentration. The functional status of 
male accessory reproductive organs can be accurately 
evaluated by determining the chemical composition of 
seminal plasma (Turner and Bagnara, 1976).  Hence, 
present investigation gives a clue that change in the 
chemical composition of the testis and other 
reproductive organs in treated groups is probably due 
to a change in the circulating androgen level. As 
testosterone plays a major if not sole role in the 
maintenance of structural integrity and functional 
activities of the accessory sex organs and reduction in 
accessory sex organ weight is a reflection of decreased 
testosterone level in the blood (Gupta et al., 2007; Patil 
et al., 2010).  
In the present study, a decrease in the protein and 
ACP activity and an increase in total free sugar and the 
activities of ALP and LDH in the testis and other 
reproductive organs like caput and cauda of epididymis, 
vas deferens, seminal vesicle and ventral prostate on 
maximum dose treatment with technical active 
constituent azadirachtin-A reveals the antiandrogenic 
property as above said biochemical parameters are 
androgen sensitive. These observations are similar to 
those found in studies (Gupta et al., 2007; Parandin et 
al., 2008; Kuang et al., 2009; Aladakatti et al., 2010) 
and reported that the structural and functional integrity 
of the reproductive organs depends on the circulating 
level of the androgen, and any small change in the 
androgen level results in the reduction in the 
biochemical parameters of organs leading to reduction 
of fertility.  
It has been reported that protein level is directly 
correlated with the secretory activity of the testis and 
accessory glands, which in turn depends on the 
androgen levels (Jones, 1977).The most pronounced 
general metabolic action of the androgen is the 
promotion of protein anabolism (Steinberger, 1971); the 
reduction in protein content observed in the present 
study may be attributed to the reduction in secretory 
activity of the testis and other organs because of the 
androgen deprivation effect which indirectly indicates 
the anti-androgenic property of these active 
constituents. It is generally known that any interference 
in the normal reproductive physiology would result in 
decrease of carbohydrate metabolizing enzymes 
(Aruldhas et al., 1982a & b). Any such decrease in the 
levels of such enzymes would result in under utilization 
of sugar and hence its accumulation in the target 
organs (Verma et al., 1980; Joshi et al., 1996; and 
Aladakatti et al., 2010). Taking into consideration the 
above reports, it can be presumed that an increase in 
the total free sugar content of testis and other organs of 
azadirachtin-A treated rats may be due to a decrease 
in the carbohydrate metabolizing enzymes, resulting in 
accumulation of sugar in the target organs.   
Both ACP and ALP are sensitive functional 
indicators of the reproductive status of animal and 
directly correlated with the sperm count. Both are 
concerned with the hydrolysis of phosphomonoesters 
releasing free phosphorus and thus responsible for the 
secretory activity of target organs (Mann et al., 1981). 
In present findings, a decline in the ACP and increase 
in ALP activity in the testis and other reproductive 
organs may possibly due to the decrease in serum 
testosterone and stimulatory glucocorticoids as well as 
degeneration of testicular germ cells (Ghosh et al., 
1990). This agrees with the observations of aqueous 
extract of Chromolaena odoratum and lyophilized 
A.indica leaf powder in rats (Yakubu et al., 2007; 
Aladakatti et al., 2010). In the present study, increase 
in LDH level observed in the testis and other 
reproductive organs of treated animals suggests the 
elevation of the substrate lactate level as LDH is one of 
the key enzymes in Embden-Mayeroff pathway of 
carbohydrate metabolism and the low activity of the 
enzyme has been used as a marker for active 
spermatogenesis. According to Sinha et al. (1995) and 
Pant and Srivastava (2003), increase in LDH activity 
level has a direct effect on testicular functions such as 
sperm count, its production and sperm morphology. In 
this study a considerable elevation in the epididymal 
and other organ’s LDH activity of the treated rats 
indicate the production of substrate lactate, suggesting 
a switch over from aerobic to anaerobic type of 
respiration or altered physiological/metabolic activity 
which may have a definite influence on androgen-
regulated glycolytic enzyme activities in the male 
accessory organs, thereby indirectly affecting the 
secretory activities of these tissues. 
In the present study of 1.5 mg/kg body weight 
treatment resulted in reducing sperm count, motility 
and sperm speed in a significant manner. It has been 
shown that androgens are essential for survival and 
motility of spermatozoa in the rat epididymis, cauda 
region appears to be the most favourable site. It is 
likely that any contraceptive agent that affects sperm 
motility would influence spermatozoa indirectly through 
disruption of epididymal epithelial cell function or act 
directly on the spermatozoa by affecting their enzymes 
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(Cooper and Young, 1999). A significant increase in the 
abnormal sperm count and inhibition of sperm forward 
movement in high dose treated rats suggests that this 
azadirachtin-A’s target is within the internal milieu of 
the epididymis or alterations in the epididymal 
epithelium in the cauda epididymis (Aladakatti et al., 
2001; Ghodesawar et al., 2004). As a result of previous 
observations of A. indica leaf powder treated rats 
(Aladakatti et al., 2001; Ghodesawar et al., 2004), it 
indicate that it is less likely that one of the active 
constituents of A.indica leaves, i.e., azadirachtin-A 
affects the sperm motility by altering the epididymis 
itself. Although, the effect of 1.5 mg / kg body weight of 
azadirachtin-A, significant increase in the abnormal 
sperm count and inhibition of sperm forward movement 
suggest that this azadirachtin-A’s target is within the 
internal milieu of the epididymis and the significant 
alterations in the epididymal epithelium in the cauda 
epididymis in A. indica leaf powder treated rats 
(Aladakatti et al., 2001; Ghodesawar et al., 2004) 
indicate that it is less likely that azadirachtin-A affects 
the sperm motility by altering the epididymis itself. 
It was suggested that these compounds cause 
androgen depletion at the target level, particularly in 
the cauda epididymis thereby affecting physiological 
maturation of the sperm (Chinoy et al., 1995). The 
observations made in this study are supported from 
studies of flavonoid-rich seed extracts of Vitex negundo 
(Das et al., 2004); methanol extract of Dendrophthoe 
falcate (Gupta and Kachhawa, 2007); aqueous extract 
of Peganum harmala (El-Dwairi and Banihani, 2007); 
and methanol subfraction of Carica papaya seeds 
(Manivannan et al., 2009).  The inhibition of fertility by 
30% in azadirachtin-A seemed to depend on the 
graded doses of subcutaneous administration for 24 
days. The male fertility potency resulting after the 
treatments, could indicate that for a 100% non-
successful contraceptive effect, it is apparently 
necessary that rats be subjected to further treatment 
with high doses or increasing duration of treatment. As 
in this study, it has been shown that known graded 
doses of azadirachtin-A with time period (24 days), 
some of the androgen dependent biochemical 
parameters exhibited considerable changes which in 
turn reduced sperm count, motility and sperm speed 
due to androgen depletion at the target level, 
particularly in the cauda epididymis thereby affecting 
physiological maturation of the sperm (Chinoy et al., 
1995). This study suggests that azadirachtin-A, at 
effective concentration and route administration, may 
be a potential use as an antifertility drug with the 
advantage of antifertility activity and without toxicity. 
In conclusion, subcutaneously administration with 
graded concentrations of azadirachtin-A (0.5, 1.0 and 
1.5 mg in suspension with 50% DMSO, respectively/kg 
body weight) to male rats produced effects at maximum 
dose on biochemical parameters of reproductive 
organs, sperm functional parameters and fertility 
potency. It can be suggested that a change in the 
chemical composition of the reproductive organs in the 
present study is probably due to a deficiency in the 
level of circulating androgen; these results indirectly 
reflect the antiandrogenic property of the azadirachtin-
A. Further, sperm functional and fertility observations, it 
can be suggested that changes in sperm parameters 
may be a general disturbance of proteins and alteration 
in the epididymal milieu probably due to androgen 
deficiency consequent upon the antiandrogenic 
/antifertility quality of azadirachtin-A. Based on the 
present findings, it can be concluded that the active 
constituent azadirachtin-A from A.indica leaves which 
probably affect the androgen synthesis and thus exhibit 
antiandrogenic effects on androgen sensitive target 
glands and such effects changes in the androgen 
sensitive biochemical and sperm parameters clearly 
indicate some dwindling in the androgenic status of the 
treated rats.  
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